Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients
- 9 July 2009
- journal article
- Published by Springer Nature in Leukemia
- Vol. 23 (11) , 2139-2146
Abstract
Decoy receptor 3 (DcR3), a member of the tumor necrosis factor (TNF) receptor superfamily, is known to be involved in cell survival and osteoclast (OC) formation. In this study, we show that malignant plasma cells and T lymphocytes from multiple myeloma (MM) bone disease patients, as well as Karpas 909, a human myeloma cell line, directly produce DcR3. By interacting with FasL, this molecule could inhibit OC apoptosis. In fact, the use of a neutralizing anti-DcR3 antibody induces a reduction of cell viability with a consequent increase of apoptotic cell number, the activation of caspase-8 and -3, and DNA fragmentation. Furthermore, we show that DcR3 supports OC formation in samples from MM patients through the upregulation of RANKL and TNF by T lymphocytes and only TNF by CD14+ cells. In conclusion, our data provide the first evidence of the expression of DcR3 in MM, and the involvement of this molecule in supporting the survival and formation of OCs from MM bone disease patients. The production of DcR3 by T lymphocytes confers these cells a role in the pathogenesis of bone disease associated with MM.Keywords
This publication has 35 references indexed in Scilit:
- The pathogenesis of the bone disease of multiple myelomaBone, 2008
- The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosisApoptosis, 2007
- Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL‐7 in an in vitro model derived from human psoriatic arthritisThe Journal of Pathology, 2007
- Attenuation of Bone Mass and Increase of Osteoclast Formation in Decoy Receptor 3 Transgenic MiceJournal of Biological Chemistry, 2007
- Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin‐15 on the cell surface and promote osteoclastogenesis in autologous monocytesArthritis & Rheumatism, 2006
- T Cells Support Osteoclastogenesis in an In Vitro Model Derived From Human Periodontitis PatientsJournal of Periodontology, 2005
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinomaInternational Journal of Cancer, 2003
- Osteoclast differentiation and activationNature, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001